Genital Warts
📧 Sign up to get email alerts when something new happens for Genital Warts.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-11-20Clinical Trial Update: A Phase I Study of Quadrivalent Human Papilloma Virus (HPV) (Types 6, 11, 16, 18) Recombinant Vaccine in HIV-Infected and HIV-Negative Pre-Adolescents, Adolescents, and Young Adults [Phase 1]
A Phase I study of the quadrivalent HPV vaccine (types 6, 11, 16, 18) in HIV-infected and HIV-negative pre-adolescents to young adults has b…
-
CLINICAL_TRIALS research · 2024-11-12Clinical Trial Update: HPV Vaccine Integrated Service Implementation Research in Cameroon [NA]
Clinical trial update on integrating HPV vaccine services in Cameroon as implementation research; not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2024-11-12Clinical Trial Update: Long-term Follow-up of Broad Spectrum Human Papillomavirus (HPV) Vaccine Study in Women (V503-021)
Long-term follow-up update of a broad-spectrum HPV vaccine study in women, with the trial currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2024-10-24Clinical Trial Update: Multilevel Interventions to Enhance Provider Recommendations for HPV Vaccination [NA]
This completed clinical trial evaluated multilevel interventions to enhance provider recommendations for HPV vaccination, with results poste…
-
CLINICAL_TRIALS research · 2024-10-09Clinical Trial Update: Effectiveness of HPV Vaccine Among Adolescents and Reproductive Women
A Mahidol University-backed clinical trial is assessing the effectiveness of the human papillomavirus vaccine in adolescents and reproductiv…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Cavitronic Ultrasonic Surgical Aspiration (CUSA) Women's Health Study
Completed clinical trial evaluating Cavitronic Ultrasonic Surgical Aspiration (CUSA) for women's health indications, including vulvar intrae…
-
FDA approval · 2024-09-16FDA Approved: ZYCLARA — Supplemental Application (Bausch Health US, LLC)
FDA approved a supplemental application for ZYCLARA (imiquimod) filed by Bausch Health US, LLC.
-
CLINICAL_TRIALS trial_result · 2024-06-20Clinical Trial Update: Peginterferon α-2b Combined CO2 Laser in Condylomata Acuminata [NA]
Clinical trial assessing peginterferon alfa-2b combined with CO2 laser for condylomata acuminata; the study is not yet recruiting.
-
CLINICAL_TRIALS research · 2024-06-07Clinical Trial Update: Evaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females [Phase 3]
Phase 3 clinical trial evaluating the efficacy, immunogenicity and safety of a 9-valent HPV recombinant vaccine in Chinese healthy female pa…
-
CLINICAL_TRIALS trial_result · 2024-06-04Clinical Trial Update: Adaptation Of An HPV Education Resource To Promote HPV Vaccination
Clinical trial update describing the adaptation of an HPV education resource to promote HPV vaccination; the study has completed and results…
-
CLINICAL_TRIALS research · 2024-05-30Clinical Trial Update: Patient Decision Aid Tool for HPV Vaccination Among Adults Ages 27-45 Years Old [NA]
A completed clinical trial evaluating a patient decision aid tool to support HPV vaccination decisions among adults aged 27-45 years.
-
CLINICAL_TRIALS research · 2024-05-08Clinical Trial Update: Impact of a Mock-up Fact-checking Extension on HPV Vaccine Misinformation: A Survey Experiment [NA]
This clinical trial update reports a survey experiment assessing whether a mock-up fact-checking extension reduces HPV vaccine misinformatio…
-
CLINICAL_TRIALS trial_result · 2024-04-17Clinical Trial Update: Immunobridging Study of 9-valent Human Papillomavirus Recombinant Vaccine in Chinese Females Aged 9 to 19 Years [Phase 3]
Immunobridging study in Phase 3 evaluating a 9-valent HPV vaccine in Chinese females aged 9 to 19; trial status is recruiting.
-
CLINICAL_TRIALS trial_result · 2024-04-17Clinical Trial Update: Immunogenicity and Safety of Quadrivalent HPV Vaccine in Healthy Chinese Female Subjects Aged 9 to 19 Years [Phase 3]
Phase 3 trial evaluating the immunogenicity and safety of a quadrivalent HPV vaccine in healthy Chinese females aged 9 to 19; currently recr…
-
CLINICAL_TRIALS trial_result · 2023-11-24Clinical Trial Update: Evaluate the Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females [Phase 3]
Phase 3 trial assessing immunogenicity and safety of a 9-valent HPV recombinant vaccine in Chinese healthy females has completed.
-
FDA approval · 2023-11-22FDA Approved: PODOFILOX — Original Application (Padagis US LLC)
FDA approved Padagis US LLC's Podofilox (podofilox) topical solution from an original ANDA for treating external genital warts caused by HPV…
-
CLINICAL_TRIALS trial_result · 2023-07-21Clinical Trial Update: A Phase Ⅲ Study to Evaluate the Efficacy, Immunogenicity, Safety of Quadrivalent HPV Recombinant Vaccine in Chinese Healthy Females [Phase 3]
Phase 3 trial evaluating a quadrivalent HPV recombinant vaccine in Chinese healthy females was terminated.
-
CLINICAL_TRIALS trial_result · 2023-04-05Clinical Trial Update: Topical NVN1000 for the Treatment of External Genital and Perianal Warts [Phase 2]
Phase 2 trial of topical NVN1000 for external genital and perianal warts completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-01-19Clinical Trial Update: Immunogenicity and Safety of V503 in Chinese Males 9 Through 19 Years Old (V503-053) [Phase 3]
Phase 3 trial update evaluating immunogenicity and safety of V503 in Chinese males aged 9–19 for genital warts; status is active not recruit…
-
CLINICAL_TRIALS trial_result · 2022-10-28Clinical Trial Update: Phase III Study Comparing the Immunogenicity of 9-valent HPV Recombinant Vaccine and Gardasil-9 [Phase 3]
Phase III study comparing immunogenicity of a 9-valent HPV recombinant vaccine with Gardasil-9; status is UNKNOWN.
-
CLINICAL_TRIALS trial_result · 2022-02-25Clinical Trial Update: Evaluate the Immunogenicity and Safety of 4-valent and 9-valent HPV Recombinant Vaccine in Chinese Healthy Females [Phase 3]
Phase 3 trial assessing immunogenicity and safety of 4-valent and 9-valent HPV recombinant vaccine in Chinese healthy females; study complet…
-
CLINICAL_TRIALS trial_result · 2022-02-07Clinical Trial Update: Study of Imiquimod Cream Prior to Ablative Therapy in External Ano-Genital Warts [Phase 4]
Phase 4 trial update evaluating imiquimod cream before ablative therapy for genital warts has completed.
-
CLINICAL_TRIALS trial_result · 2021-10-13Clinical Trial Update: Gardasil Immunogenicity With Needle-Free Injection
A completed clinical trial assessing the immunogenicity of Gardasil when administered with a needle-free injection system, with results post…
-
FDA approval · 2021-01-26FDA Approved: IMIQUIMOD — Original Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved Sun Pharmaceutical's Imiquimod as an Original Application (generic) product. It covers actinic keratosis, superficial basal…
-
CLINICAL_TRIALS trial_result · 2020-02-05Clinical Trial Update: Betaglucin 0.2% Versus Imiquimod 5% in Treatment of Ano-genital Warts: Combined Results From Triple Blind Controlled Study [Phase 3]
Phase 3 trial comparing Betaglucin 0.2% to Imiquimod 5% for genital warts shows results from a triple-blind controlled study.